| Literature DB >> 33317454 |
Nsoh Godwin Anabire1,2, Paul Armah Aryee3, Zulka Ziblim2, Jonathan Suurbaar1, Felix Ansah1, Gideon Kofi Helegbe4,5.
Abstract
BACKGROUND: Chronic Sedentary lifestyles have been linked to increased odds of stress, elevated anxiety and diminished wellbeing, inducing cytokine production and predispose to hypertension and other cardiovascular diseases. In endemic areas, Plasmodium falciparum and hepatitis B virus (HBV) infections can trigger pro-inflammatory cytokine responses. However, the impact of these infections on cytokine response profiles in individuals engaged in chronic sedentary activities is unknown. This study was aimed at addressing these concerns using a predominantly sedentary population of traders in the Tamale metropolis of Ghana.Entities:
Keywords: Cytokines; Hepatitis B; Hypertension; Malaria; Sedentary lifestyle
Year: 2020 PMID: 33317454 PMCID: PMC7737354 DOI: 10.1186/s12879-020-05692-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Differences in socio-demographic variables and stress determinants among infection groups
| Category | Sub-category | Infection status | ( | |||
|---|---|---|---|---|---|---|
| Un-infected n (%) | ||||||
| | 18–35 | 202 (54.0) | 4 (100.0) | 8 (66.7) | 10 (100.0) | 12.17, *0.058 |
| 36–55 | 124 (33.2) | 0 (0.0) | 3 (25.0) | 0 (0.0) | ||
| 56+ | 48 (12.8) | 0 (0.0) | 1 (8.3) | 0 (0.0) | ||
| | Male | 255 (68.2) | 3 (75.0) | 9 (75.0) | 10 (100.0) | 4.89, *0.180 |
| Female | 119 (31.8) | 1 (25.0) | 3 (25.0) | 0 (0.0) | ||
| | Yes | 296 (79.1) | 1 (25.0) | 9 (75.0) | 8 (80.0) | 6.98, *0.073 |
| No | 78 (20.9) | 3 (75.0) | 3 (25.0) | 2 (20.0) | ||
| | Yes | 239 (63.9) | 4 (100.0) | 7 (58.3) | 8 (80.0) | 3.51, *0.320 |
| No | 135 (36.1) | 0 (0.0) | 5 (41.7) | 2 (20.0) | ||
| | Yes | 12 (3.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.86, *0.835 |
| No | 388 (97.0) | 4 (100.0) | 12 (100.0) | 10 (100.0) | ||
| | Yes | 21 (5.6) | 1 (25.0) | 1 (8.3) | 0 (0.0) | 3.51, *0.320 |
| No | 353 (94.4) | 3 (75.0) | 11 (91.7) | 10 (100.0) | ||
| | Yes | 186 (49.7) | 2 (50.0) | 8 (66.7) | 6 (60.0) | 1.70, *0.636 |
| No | 188 (50.3) | 2 (50.0) | 4 (33.3) | 4 (40.0) | ||
| | Yes | 170 (45.5) | 0 (0.0) | 4 (33.3) | 4 (40.0) | 4.03, *0.258 |
| No | 204 (54.5) | 4 (100.0) | 8 (66.7) | 6 (60.0) | ||
| | Yes | 254 (67.9) | 4 (100.0) | 5 (41.7) | 8 (80.0) | 6.33, *0.097 |
| No | 120 (32.1) | 0 (0.0) | 7 (58.3) | 2 (20.0) | ||
* analyzed using Pearson’s chi-square test or Fisher’s exact test
χ2 = Chi-square value
p significant at < 0.05 (2-tailed)
n (%): numbers and proportions
Association between Sedentary life style and Infection status
| Infection status | Sedentary and non-sedentary groups | ( | |||
|---|---|---|---|---|---|
| > = 5 years + > = 10 h n (%) | > = 5 years + < 10 h n (%) | < 5 years + > = 10 h n (%) | < 5 years + < 10 h n (%) | ||
| Un-infected | 212 (53.0) | 96 (24.0) | 50 (12.5) | 16 (4.0) | 7.08, *0.629 |
| 2 (0.5) | 1 (0.3) | 0 (0.0) | 1 (0.3) | ||
| 7 (1.8) | 3 (0.8) | 1 (0.3) | 1 (0.3) | ||
| 7 (1.8) | 2 (0.5) | 0 (0.0) | 1 (0.3) | ||
* analyzed using Pearson’s chi-square test or Fisher’s exact test
χ2 = Chi-square value
p significant at < 0.05 (2-tailed)
n (%): numbers and proportions
Comparison of cytokine responses across different lifestyle groups
| Parameters (pg/mL) | Groups of traders based on number of working years and working hours per day | ||||
|---|---|---|---|---|---|
| ≥5 years + ≥ 10 h group | ≥ 5 years + < 10 h group | < 5 years + ≥ 10 h group | < 5 years + < 10 h group | ||
| Pro-inflammatory cytokines | Median (IQR), n | ||||
| TNF-α | 12.12 (9.54–15.38) 20 | 11.35 (9.65–11.92) 5 | 12.69 (6.91–14.51) 4 | 7.13 (4.50–12.99) 4 | 0.405 |
| IL-1β | 3.47 (2.82–4.82) 15 | 3.52 (2.59–5.503) 4 | 4.56 (3.30–5.73) 3 | 3.37 (1.97–4.56) 3 | 0.759 |
| IL-6 | 34.88 (25.83–47.90) 20 | 28.41 (23.06–36.30) 5 | 39.55 (21.62–52.94) 4 | 25.32 (21.62–131.3) 4 | 0.608 |
| IFN-γ | 6.355 (3.94–9.83) 18 | 5.39 (3.73–8.44) 5 | 7.34 (3.69–10.77) 3 | 7.95 (3.01–14.20) 4 | 0.890 |
| IL-8 | 14.21 (10.32–36.89) 13 | 12.16 (4.09–20.22) 2 | 35.94 (11.06–404.4) 4 | 15.93 (3.01–24.02) 3 | 0.773 |
| IL-12 | 4.328 (3.07–5.73) 18 | 4.27 (3.45–6. 87) 5 | 2.161 (1.79–5.86) 3 | 3.872 (1.82–5.96) 3 | 0.667 |
| Anti-inflammatory cytokines | Median (IQR), n | ||||
| IL-10 | 28.3 (14.17–52.01) 18 | 16.65 (14.91–50.76) 4 | 13.41 (5.69–29.60) 4 | 17.6 (15.06–27.41) 3 | 0.342 |
| IL-7 | 17.72 (14.41–23.66) 21 | 11.83 (10.38–24.46) 5 | 17.98 (11.91–35.01) 4 | 10.93 (6.76–17.98) 4 | 0.222 |
| IL-13 | 27.17 (19.65–35.52) 15 | 27.47 (15.37–42.98) 5 | 23.26 (13.22–34.90) 4 | 26.27 (15.59–39.87) 4 | 0.927 |
*; analyzed by Krulskal-Wallis test
p significant at < 0.05 (2-tailed)
IQR interquartile range
n number of samples
Comparison of cytokine responses among participants with hypertension or anemia
| Cytokines (pg/mL) | Category | Hypertension | Anemia | ||||
|---|---|---|---|---|---|---|---|
| n | Median (IQR) | N | Median (IQR) | ||||
| TNF-α | Yes | 22 | 11.48 (9.75–14.91) | 0.281 | 13 | 11.44 (10.28–14.77) | 0.573 |
| No | 11 | 9.91 (6.74–12.95) | 20 | 11.62 (6.82–13.69) | |||
| IL-1β | Yes | 19 | 3.55 (2.82–5.28) | 0.563 | 11 | 3.91 (3.30–5.28) | 0.123 |
| No | 6 | 3.39 (2.66–4.57) | 14 | 3.03 (2.377–4.57) | |||
| IL-6 | Yes | 21 | 40.64 (27.78–47.54) | 0.113 | 13 | 37.09 (27.78–43.53) | 0.957 |
| No | 12 | 27.26 (21.49–37.50 | 20 | 30.43 (23.26–52.17) | |||
| IFN-γ | Yes | 21 | 6.62 (3.96–10.12) | 0.378 | 12 | 7.12 (5.03–9.38) | 0.409 |
| No | 9 | 6.89 (3.59–7.41) | 18 | 6.26 (3.60–8.96) | |||
| IL-8 | Yes | 16 | 15.44 (10.25–56.46) | 0.449 | 8 | 15.44 (10.95–51.21) | 0.764 |
| No | 6 | 12.79 (8.72–21.6) | 14 | 13.7 (9.01–29.86) | |||
| IL-12 | Yes | 21 | 4.01 (2.81–5.82) | 0.989 | 13 | 4.47 (3.35–5.94) | 0.519 |
| No | 8 | 4.54 (2.95–5.60) | 16 | 3.99 (2.72–5.35) | |||
| IL-10 | Yes | 20 | 24.62 (16.57–47.64) | 0.220 | 12 | 20.55 (5.21–40.69) | 0.922 |
| No | 9 | 14.39 (10.33–61.24) | 17 | 24.37 (13.52–51.11) | |||
| IL-7 | Yes | 22 | 18.16 (11.7–22.06) | 0.582 | 13 | 19.24 (17.11–23.66) | 0.082 |
| No | 12 | 14.41 (11.45–23.63) | 21 | 13.99 (10.38–21.45) | |||
| IL-13 | Yes | 19 | 27.47 (20.06–37.07) | 0.159 | 13 | 29.9 (21.79–38.55) | 0.205 |
| No | 9 | 17.68 (13.24–34.71) | 15 | 25.36 (14.89–34.08) | |||
; analyzed by Mann-Whitney U test at < 0.05 level of statistical significance
p significant at < 0.05 (2-tailed)
IQR interquartile range
n number of samples
Comparison of serum cytokines levels across the different infection groups
| Parameters (pg/mL) | Infection status | ||||
|---|---|---|---|---|---|
| Un-infected | |||||
| Pro-inflammatory cytokines | Median (IQR), n | ||||
| TNF-α | 11.52 (8.55–13.85) 11 | 8.26 (4.49–26.63) 4 | 11.44 (6.93–12.56) 9 | 12.95 (10.97–15.59) 9 | 0.290 |
| IL-1β | 4.56 (2.67–6.34) 9 | 2.94 (1.97–4.14) 3 | 3.07 (2.65–4.09) 6 | 3.55 (3.12–4.82) 7 | 0.442 |
| IL-6 | 37.09 (24.44–48.26) 11 | 32.13 (19.09–165.8) 3 | 28.70 (22.68–39.35) 9 | 34.52 (37.59–55.42) 10 | 0.686 |
| IFN-γ | 6.00 (3.18–8.30) 10 | 7.79 (3.22–16.00) 3 | 6.99 (5.70–9.38) 8 | 6.10 (3.74–9.85) 9 | 0.801 |
| IL-8 | 47.38 (7.71–395.00) 9 | 10.17 (5.51–20.22) 3 | 12.99 (10.54–19.48) 5 | 15.93 (9.15–23.60) 5 | 0.546 |
| IL-12 | 2.97 (1.82–5.02) 10 | 3.87 (2.87–4.00) 3 | 4.54 (3.75–5.12) 7 | 5.68 (3.93–6.32) 9 | 0.154 |
| Anti-inflammatory cytokines | Median (IQR), n | ||||
| IL-10 | 17.18 (11.82–25.67) 9 | 24.86 (15.06–49.26) 3 | 23.20 (11.86–47.39) 8 | 27.41 (17–99.52) 9 | 0.201 |
| IL-7 | 16.67 (11.33–21.49) 11 | 10.40 (6.70–18.81) 4 | 17.54 (11.85–23.66) 9 | 19.50 (16.79–25.00) 10 | 0.190 |
| IL-13 | 19.65 (15.86–35.49) 9 | 27.47 (25.36–41.54) 3 | 25.55 (13.11–38.54) 8 | 31.50 (21.60–35.35) 8 | 0.763 |
*; analyzed by Krulskal-Wallis test at < 0.05 level of statistical significance
p significant at < 0.05 (2-tailed)
IQR interquartile range
n number of samples
Comparison of serum cytokines levels across sedentary and non-sedentary groups with different infections
| Parameters (pg/mL) | Sedentary groups with different infection status | ||||
|---|---|---|---|---|---|
| Sedentary and Infected group | Sedentary and Un-infected | Non-sedentary and Infected group | Non-sedentary and Un-infected group | ||
| Pro-inflammatory cytokines | Median (IQR), n | ||||
| TNF-α | 12.95 (10.03–15.59) 13 | 10.72 (8.55–12.89) 7 | 9.84 (6.45–11.92) 9 | 12.69 (7.93–14.51) 4 | 0.349 |
| IL-1β | 3.35 (2.91–4.67) 10 | 3.91 (1.98–9.58) 5 | 3.14 (2.36–4.59) 6 | 4.56 (3.62–5.44) 4 | 0.615 |
| IL-6 | 37.63 (26.48–50.68) 13 | 33.21 (25.49–47.9) 8 | 27.78 (20.98–36.3) 9 | 42.01 (21.21–56.59) 3 | 0.534 |
| IFN-γ | 6.89 (3.83–10.18) 17 | 6.00 (3.86–7.47) 8 | 6.25 (3.87–8.81) 12 | 5.52 (2.16–9.92) 4 | 0.867 |
| IL-8 | 13.6 (10.25–19.34) 8 | 47.38 (7.60–395.00) 5 | 15.93 (7.36–22.12) 5 | 35.95 (5.36–404.4) 4 | 0.685 |
| IL-12 | 4.68 (3.78–5.83) 12 | 4.12 (2.75–5. 86) 7 | 4.27 (3.87–5.96) 7 | 1.99 (1.80–3.54) 4 | 0.119 |
| Anti-inflammatory cytokines | Median (IQR), n | ||||
| IL-10 | 34.4 (23.94–69.84) 13 | 12.66 (11.82–35.28) 5 | 16.49 (14.39–27.41) 7 | 17.37 (11.53–29.71) 4 | 0.098 |
| IL-7 | 20.22 (17.72–26.28) 7 | 17.04 (11.92–20.51) 8 | 19.24 (10.46–19.76) 3 | 17.81 (10.53–34.92) 4 | 0.461 |
| IL-13 | 30.14 (25.00–36.64) 10 | 19.65 (15.86–48.81) 5 | 27.47 (14.63–38.20) 9 | 23.26 (15.70–34.90) 4 | 0.852 |
*; analyzed by Krulskal-Wallis test at < 0.05 level of statistical significance
p significant at < 0.05 (2-tailed)
IQR interquartile range
n number of samples